{"id":"panhematin","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT02922413","NCT01715025","NCT00882804","NCT00467610","NCT05788172","NCT02935400","NCT01855841","NCT02180412","NCT01430156","NCT06409182","NCT01206582"],"aliases":["Glucose"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"brandName":"Panhematin","companyId":"rush-university-medical-center","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"Rush University Medical Center","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"Panhematin","indications":{"approved":[{"name":"Acute intermittent porphyria","diseaseId":"acute-intermittent-porphyria","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02922413","phase":"Phase 2","title":"Safety and Efficacy of Panhematin™ for Prevention of Acute Attacks of Porphyria","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","isPivotal":false,"enrollment":13,"indication":"Acute Intermittent Porphyria, Hereditary Coproporphyria","completionDate":"2023-12-27"},{"nctId":"NCT01715025","phase":"Phase 4","title":"An Open-labeled Pilot Study to Determine the Efficacy of an E2//Nomegestrol Acetate (E2/NOMAC)Combination Oral Contraceptive (COC) in the Management of Heavy Menstrual Bleeding (HMB)","status":"UNKNOWN","sponsor":"Sydney Centre for Reproductive Health Research","isPivotal":false,"enrollment":30,"indication":"Menorrhagia","completionDate":"2015-08"},{"nctId":"NCT00882804","phase":"Phase 1","title":"Effect of Hemin on Heme-Oxygenase-1 Activity in Healthy Subjects","status":"COMPLETED","sponsor":"Mayo Clinic","isPivotal":false,"enrollment":10,"indication":"Healthy Volunteers","completionDate":"2009-04"},{"nctId":"NCT00467610","phase":"Phase 2","title":"A Phase 2, Open-Label, Multiple-Dose Study Investigating the Efficacy and Safety of Panhematin in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome","status":"TERMINATED","sponsor":"Rush University Medical Center","isPivotal":false,"enrollment":6,"indication":"Myelodysplastic Syndrome","completionDate":"2009-01"},{"nctId":"NCT05788172","phase":"N/A","title":"Quantifying Menstrual Blood Loss: Validating the Methodology for Stable Iron Isotopes Dilution Against the Alkaline Hematin Method","status":"COMPLETED","sponsor":"Isabelle Herter-Aeberli","isPivotal":false,"enrollment":10,"indication":"Iron-deficiency, Menorrhagia","completionDate":"2023-08-30"},{"nctId":"NCT02935400","phase":"N/A","title":"Acute Porphyrias: Biomarkers for Disease Activity and Response to Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Medical Branch, Galveston","isPivotal":false,"enrollment":50,"indication":"Acute Intermittent Porphyria, Hereditary Coproporphyria","completionDate":"2026-12-31"},{"nctId":"NCT01855841","phase":"Phase 2","title":"Prevention of Post-ERCP Acute Pancreatitis by Heme-oxygenase Activation Through the Administration of Hemin : a Prospective, Randomized Double Blind Controlled Trial","status":"COMPLETED","sponsor":"Erasme University Hospital","isPivotal":false,"enrollment":284,"indication":"Post-ERCP Acute Pancreatitis","completionDate":"2021-06"},{"nctId":"NCT02180412","phase":"Phase 2","title":"A Double-blind, Randomized, Placebo-controlled, Parallel Group Trial on the Efficacy and Safety of PanhematinTM in the Treatment of Acute Attacks of Porphyria","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","isPivotal":false,"enrollment":20,"indication":"Acute Porphyrias","completionDate":"2022-02-03"},{"nctId":"NCT01430156","phase":"Phase 3","title":"A Randomised Placebo-Controlled Trial to Investigate the Effect of Pre-treatment With Haem Arginate (Normosang) on Heme-Oxygenase 1 (HO-1) Upregulation in Recipients of Deceased Donor Kidneys","status":"COMPLETED","sponsor":"University of Edinburgh","isPivotal":true,"enrollment":40,"indication":"Graft Failure, Ischemia-reperfusion Injury","completionDate":"2013-08"},{"nctId":"NCT06409182","phase":"NA","title":"A Prospective Pilot Study to Evaluate the Diagnostic Performance of a Wireless Sensor Capsule in Detection of Upper Gastrointestinal Bleeding","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","isPivotal":false,"enrollment":30,"indication":"UGI Bleed","completionDate":"2025-05-30"},{"nctId":"NCT01206582","phase":"Phase 2","title":"A Pilot Study of Hemin Therapy for Gastroparesis","status":"COMPLETED","sponsor":"Mayo Clinic","isPivotal":false,"enrollment":20,"indication":"Gastroparesis, Diabetes Mellitus","completionDate":"2014-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Hematology"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}